BRCA variants linked to increased cancer survival: study

Patients with inherited genetic mutations may be more responsive to chemotherapy, researchers say

Women with breast or ovarian cancer and BRCA1/2 or other pathogenic gene variants may be less likely than non-carriers to die from their cancer in the short term, US researchers report.

pink ribbon signifying breast cancer risk

"These findings will help oncologists counsel patients about the likely outcome of their cancer and reassure them that having an inherited genetic mutation is, if anything, a good prognostic factor," said lead author Dr Allison Kurian of Stanford University School of Medicine, in California,